Decoding the proteins behind drug-resistant superbugs

Sep 16, 2011 By Louise Lerner
The structure of NDM-1 shows the protein's enlarged active site, which lets it latch onto and disable a broad range of antibiotics.

Penicillin and its descendants once ruled supreme over bacteria. Then the bugs got stronger, and hospitals have reported bacterial infections so virulent that even powerful antibiotics held in reserve for these cases don't work.

To create the next line of defense against the most drug-resistant pathogens, scientists at the U.S. Department of Energy's Argonne National Laboratory and Texas A&M University have decoded the structure of a that confers drug resistance against our best antibiotics. The work could provide the foundation for new treatments to fight emerging drug-resistant .

β-lactam antibiotics are the most widely used antibacterials in the world because they effectively kill bacteria, but are minimally toxic to human cells—which means they have few side effects. But 1999 sounded the end of the reign of β-lactams. That year, a patient died in a Swedish from an infection that didn't respond to antibiotics.

Penicillin was the original β-lactam, but as bugs evolved to fight it, scientists developed an entire family of related antibiotics, including amoxicillin, cephalexin and imipenem. The drugs work by blocking the bacteria's cell walls from growing normally. The latest class, called carbapenems, is generally held as the last line of defense against the toughest drug-resistant infections, like MRSA.

But resistant even to carbapenems have begun spreading across the world, and they can trade this ability not only among each other but to other species of bacteria as well.

Scientists tracked down a gene that allows bacteria to resist these antibiotics, called NDM-1. The gene codes for a protein that latches onto part of the antibiotic molecule: the β-lactam ring that gives the family its name. The rings are rigid, and once they break apart, the antibiotic is useless. "That's why with NDM-1 genes are so deadly,” explained Andrzej Joachimiak, an Argonne Distinguished Fellow who co-authored the study.

But NDM-1's greatest trick is that it can disable the entire spectrum of β-lactam antibiotics. Each different antibiotic has a different molecular structure. Argonne researchers needed to know how one protein could break the rings in a dozen different configurations.

Joachimiak, who has a joint appointment with Argonne and the University of Chicago, took up the challenge with colleagues at the Midwest Center for Structural Genomics and Texas A&M University.

One of the most powerful tools in a biologist's kit is protein crystallography, which zooms down to the molecular level to get a picture of what the protein looks like. Protein crystals are tiny things: a thousand of them could sit side by side in a human hair. But intense X-rays from large synchrotrons like Argonne's Advanced Photon Source can be used as a "camera”: detectors collect the data from X-rays bouncing off the crystallized protein and use it to reconstruct the enzyme's structure, atom by atom.

The team managed to capture the NDM-1 enzyme in three different states. They found that NDM-1's active site, where it latches onto the antibiotic, is abnormally enormous, and flexible—like a mouth that is so large that it can capture the rings from a dozen different , no matter their shape.

Decoding the structure allows scientists and companies to study the molecule for weaknesses: places where the structure could be attacked to disrupt its function. Joachimiak and the team are already beginning another study to test one way to neutralize the enzyme.

The study, "Structure of Apo- and Monometalated Forms of NDM-1—A Highly Potent Carbapenem-Hydrolyzing Metallo-β-Lactamase”, was funded by the National Institutes of Health and has been published online in the journal PLoS ONE</i>.

Explore further: Bubble wrap serves as sheet of tiny test tubes in resource-limited regions

Related Stories

New knowledge will boost fight against superbug

Sep 07, 2011

A breakthrough in the fight against drug-resistant infections is one step closer following the discovery of the structure of NDM-1: a vicious form of bacteria that is currently resistant to the most powerful antibiotics available.

The structure of resistance

Feb 22, 2008

A team of scientists from the University Paris Descartes has solved the structure of two proteins that allow bacteria to gain resistance to multiple types of antibiotics, according to a report in EMBO reports this month. ...

Bacteria build walls to withstand antibiotics

Nov 01, 2005

Antibiotic resistant bacteria, which are proliferating in hospitals and causing major headaches for physicians, cheat death by finding ways to fortify their cell walls against the deadly drugs. The question is: how? New res ...

Superbugs top focus of leading microbiology meet

Sep 11, 2010

Serious public health risks due to a lack of new antibiotics at a time of rising antibiotic-resistant "superbugs" will be the main focus of a top microbiology conference in Boston that starts Sunday.

Recommended for you

Chemists eye improved thin films with metal substitution

23 hours ago

The yield so far is small, but chemists at the University of Oregon have developed a low-energy, solution-based mineral substitution process to make a precursor to transparent thin films that could find use ...

Essential oils may provide good source of food preservation

Jul 21, 2014

A new study in the Journal of Food Science, published by the Institute of Food Technologists (IFT), found that essential oils may be able to be used as food preservatives in packaging to help extend the shelf-life of foo ...

User comments : 0